Listar DBCFI-Artículos, capítulos... por autor "097c32d7-6ae7-4ab2-a689-3f66e6cccaf9"

Mostrando ítems 1-3 de 3

    • A plasma fatty acid profile associated to type 2 diabetes development: from the CORDIOPREV study 

      Villasanta-González, Alejandro; Alcalá Díaz, Juan Francisco; Vals-Delgado, Cristina; Arenas, Antonio Pablo; Cardelo, Magdalena P.; Romero-Cabrera, Juan Luis; Rodríguez-Cantalejo, Fernando; Delgado-Lista, Javier; Malagón, María M.; Pérez-Martínez, Pablo; Schulze, Matthias B.; Camargo García, A.; López-Miranda, José (Springer, 2021)
      Purpose: The prevalence of type 2 diabetes mellitus (T2DM) is increasing worldwide. For this reason, it is essential to identify biomarkers for the early detection of T2DM risk and/or for a better prognosis of T2DM. We ...

    • Changes in quantity plant‑based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV study 

      Gutiérrez Mariscal, Francisco Miguel; Alcalá-Diaz, Juan F.; Quintana-Navarro, Gracia M.; Cruz Ares, Silvia de la; Torres‑Peña, J.D.; Cardelo, Magdalena P.; Arenas de Larriva, Antonio P.; Malagón, María M.; Romero-Cabrera, Juan Luis; Ordovás, José María; Pérez Martínez, Pablo; Delgado-Lista, Javier; Yubero-Serrano, Elena M.; López Miranda, José; López Miranda (Springer, 2023)
      Purpose: Diabetes remission is a phenomenon described in the context of drastic weight loss due to bariatric surgery or low-calorie diets. Evidence suggests that increasing the intake of plant protein could reduce the risk ...

    • Endothelial Dysfunction and Advanced Glycation End Products in Patients with Newly Diagnosed Versus Established Diabetes: From the CORDIOPREV Study 

      Cruz‐Ares, Silvia de la; Cardelo, Magdalena P.; Gutiérrez Mariscal, Francisco Miguel; Torres‑Peña, J.D.; García-Ríos, Antonio; Katsiki, Niki; Malagón, María M.; López-Miranda, José; Pérez-Martínez, Pablo; Yubero-Serrano, Elena M. (MDPI, 2020)
      Endothelial dysfunction and intima-media thickness of common carotid arteries (IMT-CC) are considered subclinical markers of atherosclerotic cardiovascular disease (ASCVD). Advanced glycation end products (AGEs) are increased ...